CSPAX | OGICX | CSPAX / OGICX | |
Total Expense Ratio | 1.06 | 1.90 | 56% |
Annual Report Gross Expense Ratio | 1.06 | 1.90 | 56% |
Fund Existence | 24 years | 32 years | - |
Gain YTD | 9.967 | 5.675 | 176% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 80.3B | 2.4B | 3,350% |
Annual Yield % from dividends | 0.58 | 0.00 | - |
Returns for 1 year | 10.28 | 1.57 | 655% |
Returns for 3 years | 25.82 | -1.03 | -2,512% |
Returns for 5 years | 14.53 | -31.65 | -46% |
Returns for 10 years | 59.78 | 10.43 | 573% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VEU | 69.58 | 0.05 | +0.07% |
Vanguard FTSE All-Wld ex-US ETF | |||
MSLC | 52.83 | -0.05 | -0.09% |
Morgan Stanley Pathway Large Cap Eq ETF | |||
EDIV | 39.01 | -0.05 | -0.13% |
SPDR® S&P Emerging Markets Dividend ETF | |||
PBE | 67.68 | -0.13 | -0.19% |
Invesco Biotechnology & Genome ETF | |||
HISF | 44.77 | -0.09 | -0.20% |
First Trust High Income Strat Foc ETF |